Log In
Print
BCIQ
Print
Print this Print this
 

SparVax (Recombinant protective antigen (rPA) anthrax vaccine)

  Manage Alerts
Collapse Summary General Information
Company PharmAthene Inc.
DescriptionSecond-generation recombinant protective antigen (rPA) anthrax vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase II
IndicationAnthrax
Partner

Medison Pharma Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today